69
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The RAS/RAF/MAP kinase-ERK kinase (MEK)/extracellular-signal-regulated kinase (ERK) (MAPK) and the PI3K/AKT/mammalian target of rapamycin (mTOR) (PI3K) pathways are frequently deregulated in human cancer as a result of genetic alterations in their components or upstream activation of cell-surface receptors. These signalling cascades are regulated by complex feedback and cross-talk mechanisms.

          Related collections

          Author and article information

          Journal
          Expert Opin Ther Targets
          Expert opinion on therapeutic targets
          Informa UK Limited
          1744-7631
          1472-8222
          Apr 2012
          : 16 Suppl 2
          Affiliations
          [1 ] Cell Biology and Biotherapy Unit, INT-Fondazione Pascale, 80131 Naples, Italy.
          Article
          10.1517/14728222.2011.639361
          22443084
          40e2d06a-d7a5-4e58-b8cb-6e5b8e7224e7
          History

          Comments

          Comment on this article